drugset / Trial / NCT04536805

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

NCT04536805

Phase 1/2 Active not recruiting 44 enrolled Institut Cancerologie de l'Ouest
Non-randomizedSequentialOpen-labelTreatment

Summary

This phase I/II escalation dose study is assessing the efficacy of the recommended dose of stereotactic re-irradiation (SBRT) of relapses within the prostatectomy bed, potentiated by metformin

Timeline

Start
2020-11-17
Primary completion
2031-11
Completion
2031-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1700 mg Oral

Indications